Clinical Trials Search Results

Results 11-20 of 427 for your search
Show Search Criteria
Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716 / KEYNOTE-716)
Status: Active
Age: 12 years and over
Gender: Male or Female
Location: 25 locations
Nivolumab with or without Ipilimumab in Treating Younger Patients with Recurrent or Refractory Solid Tumors or Sarcomas
Status: Active
Age: 1 to 30 years
Gender: Male or Female
Location: 24 locations
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051 / KEYNOTE-051)
Status: Active
Age: 6 months to 17 years
Gender: Male or Female
Location: 19 locations
Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma
Status: Active
Age: 18 to 99 years
Gender: Male or Female
Location: 18 locations
Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 18 locations
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 15 locations
Talimogene Laherparepvec and Pembrolizumab in Treating Patients with Stage III-IV Melanoma
Status: Active
Age: 18 years and over
Gender: Male or Female
Location: 15 locations